Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 0.724% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a. Cc1cc(C)c2cc(C(c3nnnn3CC3CCCO3)N3CCN4CCCC4C3)c(=O)[nH]c2c1
b. Cc1ccc(CN2Cc3cccc4c3[C@@H](CC2=O)[C@H](O)[C@H](O)C4)cc1
c. CCCn1nnc(NC(=O)/C=C/c2ccc(C(C)C)cc2)n1
Answer: c. CCCn1nnc(NC(=O)/C=C/c2ccc(C(C)C)cc2)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCn1nnc(NC(=O)/C=C/c2ccc(C(C)C)cc2)n1
CCCn1nnc(NC(=O)/C=C/c2ccc(C(C)C)cc2)n1
(E)-3-(4-propan-2-ylphenyl)-N-(2-propyltetrazol-5-yl)prop-2-enamide